한국유나이티드 제약

연구개발

전문가와 협업을 통해 다양한 R&D에 투자 함으로써 언제나 더 나은 미래를 모색 합니다.

HOME

2026
- UI111(Lipid modifying agent)
  New Combination
- UI009(COPD)
  Inhaler
2027
- UI059(GERD)
  New Combination
- UI106(Asthma, COPD)
  Inhaler
- UI083(GERD)
  New Combination
- UI064(Allergic rhinitis)
  New Combination
- UI122(Bronchitis)
  ETC
2028
- UI112(Anti-Obesity)
  ETC
2029
- UI118(Arthritis)
  New dosage form
- UI060(NSAIDs)
  New Combination
2030
- UI113, UI114(Lipid modifying agent)
  New Combination
- UI117(Alopecia)
  New dosage form
- UI087, UI088(Antidiabetics)
  New Combination
2031
- UI066(Vasodilators)
  New dosage form
- UI116(NSAIDs)
  New Combination
수립예정
- UI016(Antidiabetics)
  New dosage form
- UI125(NSAIDs)
  New dosage form
- UI126, UI127(Lipid modifying agent)
  New Combination
- UI081, UI082(Lipid modifying agent)
  New Combination
- UI123, UI124(Lipid modifying agent)
  New Combination